Market Research Logo

Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021)

Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021)

Scope of the Report

The report entitled “Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global injectable anti-psychotic market, with detailed analysis of market size and growth, and segmentation of the industry.

The report also includes a detailed regional analysis of the long acting injectable anti-psychotic market in the region of the US. Under competitive landscape, different products in the long acting injectable anti-psychotic market have been compared on the basis of different parameters such as dosing frequency, patent expiry, injection sites, label, storage, needles and available strengths. Also, a financial comparison of long acting injectable market players in the US has been done.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global long acting injectable anti-psychotic market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Johnson & Johnson, Eli Lily and Company, Alkermes Public Limited Company and Lundbeck are some of the key players operating in the global long acting injectable anti-psychotic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Country Coverage

The US

Company Coverage

Johnson & Johnson
Eli Lily and Company
Alkeremes Public Limited Company
Lundbeck

Executive Summary

Anti-psychotic refers to a class of medicine used for the treatment of psychosis and various other emotional and mental conditions. Psychosis consist of delusions, hallucinations, paranoia and disordered thought. It is a condition in which a person experiences thought disorder and personality changes. Long acting injectable anti-psychotics are a sub type of antipsychotics which were primarily developed to improve the treatment of schizophrenia.

The global long acting injectable anti-psychotic market can be studied on the basis of different products and on the basis of prescription. These products are different types of long acting injectable anti-psychotic namely Invega Sustenna/ Trinza, Risperdal Consta, Abilify Maintena, Zyprexa, Aristada and many more.

The global long acting injectable anti-psychotic market is expected to increase at a healthy rate during the forecast period (2017-2021). The global long acting injectable anti-psychotic market is supported by various growth drivers, such as increasing cases of schizophrenia, rising number of bipolar disorder patients and non adherence to oral anti-psychotic.

However, side effect associated with anti-psychotic and patent expiry of some of the leading brands are some of the challenges faced by the market. Aging dernography, grant of approval to Trevicta in European Commission, third party proprietary technologies and label expansion of Abilify Maintena are some of the latest trends in the global long acting injectable anti-psychotic market.


1. Executive Summary
2. Introduction
2.1 Psychosis: An Overview
2.1.1 Psychiatric Disorder
Table 1: Psychiatric Disorder
2.1.2 Schizophrenia
2.1.3 Bipolar Disorder
2.2 Anti-psychotic: An Overview
2.3 Working Mechanism of Anti-psychotic
2.4 Long Acting Anti-psychotic Injections: An Overview
2.5 Long Acting Anti-psychotic Injections: Drugs Overview
3. Global Market Analysis
3.1 Global Anti-psychotic Market: An Analysis
3.1.1 Global Anti-psychotic Market by Value
Table 2: Global Anti-psychotic Market by Value; 2011-2016 (US$ Billion)
Table 3: Global Anti-psychotic Market by Value; 2017-2021 (US$ Billion)
3.1.2 Global Anti-psychotic Market by Products
Table 4: Global Anti-psychotic Market by Products; 2016
3.1.3 Global Anti-psychotic Market on the Basis of Prescription
Table 5: Global Anti-psychotic Market by Prescription; 2016
3.2 Global Long Acting Injectable Anti-psychotic Market: An Analysis
3.2.1 Global Long Acting Injectable Anti-psychotic Market by Value
Table 6: Global Long Acting Injectable Anti-psychotic Market by Value; 2015-2021 (US$ Billion)
3.2.2 Global Long Acting Injectable Anti-psychotic Market Value by Product
Table 7: Global Long Acting Injectable Anti-psychotic Market Value by Product; 2016
3.2.3 Global Long Acting Injectable Anti-psychotic Market Volume by Products
Table 8: Global Long Acting Injectable Anti-psychotic Market Volume by Products; 2016
3.2.4 Global Long Acting Injectable Anti-psychotic Market by Region
Table 9: Global Long Acting Injectable Anti-psychotic Market by Region; 2016
3.3 Global Long Acting Injectable Anti-psychotic Market: Product Analysis
3.3.1 Global Abilify Maintena Market by Value
Table 10: Global Abilify Maintena Market by Value; 2015-2021 ( US$ Million)
3.3.2 Global Aristada Market by Value
Table 11: Global Aristada Market by Value; 2015-2021 (US$ Million)
3.3.3 Global Invega Sustenna/Trinza Market by Value
Table 12: Global Invega Sustenna Market by Value; 2015-2021 (US$ Billion)
3.3.4 Global Risperdal Consta Market by Value
Table 13: Global Risperdal Consta Market by Value; 2015-2021(US$ Million)
3.3.5 Global Zyprexa Market by Value
Table 14: Global Zyprexa Market by Value; 2016-2021(US$ Million)
3.3.6 Global Zyprexa Market by Region
Table 15: Global Zyprexa Market by Region; 2016
4. Regional Analysis
4.1 The US Long Acting Injectable Anti-psychotic Market: An Analysis
4.1.1 The US Long Acting Injectable Anti-psychotic Market by Value
Table 16: The US Long Acting Injectable Anti-psychotic Market by Value 2016-2021 (US$ Billion)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Cases of Schizophrenia
Table 17: Schizophrenia Patients in the US;2015-2025 (‘000)
5.1.2 Rising Bipolar Disorder Patients
Table 18: Bipolar Disorder Patients in the US; 2017-2025 (‘000)
5.1.3 Non Adherence to Oral Anti-psychotic
5.2 Challenges
5.2.1 Side Effects of Anti-psychotic
Table 19: Side Effects of Injectable Anti-psychotic
5.2.2 Patent Expirations of Certain Brands
Table 20: Antipsychotic Patent Expiry Dates
5.3 Market Trends
5.3.1 Aging Demography
Table 21: Global Population (65 years and Above); 2011-2015 (Million)
5.3.2 Grant of Approval to Trevicta in European Commission
5.3.3 Third Party Proprietary Technologies
5.3.4 Expanding Labeling of Abilify Maintena
6. Competitive Landscape
6.1 Global Long Acting Injectable Anti-psychotic Market Product Comparison
Table 22: Global Long Acting Injectable Antipsychotic Market Products Comparison
6.2 US Long Acting Injectable Anti-psychotic Market by Players
Table 23: US Long Acting Injectable Antipsychotic Market by Players; 2016
7. Company Profiling
7.1 Johnson & Johnson
7.1.1 Business Overview
7.1.2 Financial Overview
Table 24: Johnson & Johnson Sales; 2012-2016 (US$ Billion)
Table 25: Johnson & Johnson Sales by Segments; 2016
7.1.3 Business Strategy
7.2 Eli Lily and Company
7.2.1 Business Overview
7.2.2 Financial Overview
Table 26: Eli Lily and Company Revenues; 2012-2016 (US$ Billion)
Table 27: Eli Lily and Company Revenues by Segments; 2016
7.2.3 Business Strategy
7.3 Alkeremes Public Limited Company
7.3.1 Business Overview
7.3.2 Financial Overview
Table 28: Alkermes Revenues; 2012-2016 (US$ Million)
Table 29: Alkermes Revenues by Region; 2016
7.3.3 Business Strategy
7.4 Lundbeck
7.4.1 Business Overview
7.4.2 Financial Overview
Table 30: Lundbeck Revenues; 2012-2016 (US$ Billion)
Table 31: Lundbeck Revenues by Products; 2016
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report